Xconomy San Diego Forum: San Diego Life Sciences 2030

Start Date: 03/31/2010
End Date: 03/31/2010
Time: 5:30 p.m. - 8:30 p.m.
Location: Biogen Idec, 5200 Research Place, San Diego, CA 92122
Contact Name: Michele Gerus
Contact Email: mgerus@xconomy.com
Contact Phone: 619 564 6066

Registration: 5:30 - 6:00 pm
Program: 6:00 - 7:30 pm
Networking reception: 7:30 - 8:30 pm

Panelists

Moderator: John Mendlein, Chairman of the Board, Fate Pharmaceuticals

--Paul Schimmel, Professor of Chemical Biology, The Scripps Research Institute
Cofounder or founding director of eleven biotechnology companies, of
which six (Alkermes, Alnylam Pharmaceuticals, Avicena Group, Cubist
Pharmaceuticals, Momenta Pharmaceuticals, Repligen Corporation) are
publicly traded.

--Dan Bradbury, President and CEO, Amylin Pharmaceuticals


--Fred "Rusty" Gage, Professor and Vi and John Adler Chair for
Research on Age-Related Neurodegenerative Diseases, Salk Institute for
Biological Studies

Bonus Feature: Meet top executives from emerging life sciences
enterprises, who will provide brief introductions to their
organizations.

Receptos
Ambrx
Helixis
Biogen Idec New Ventures